The American Heart Association scientific statement reviewed recent evidence and concluded that consuming up to 400 mg of caffeine per day—about up to five 8-ounce cups of regular caffeinated coffee—is generally safe for most adults and may be associated with lower risk of certain cardiovascular outcomes for some people. The statement emphasizes that higher caffeine amounts, particularly the concentrated levels found in energy drinks and energy shots, have been associated with cardiovascular harm such as increased blood pressure and irregular heart rhythm.
Most human studies on caffeine focus on coffee, and observed benefits may reflect other bioactive compounds in coffee (antioxidant and anti-inflammatory substances) rather than caffeine alone. Many studies are observational and cannot establish causation. Additives commonly mixed into coffee—sugar, flavored syrups, milk or cream—may reduce any potential health benefits linked to black caffeinated coffee.
Caffeine consumed in coffee is metabolized by the liver and typically reaches peak blood concentrations within about an hour for most people. Individual factors—genetics, age, metabolic rate and habitual caffeine use—affect how quickly caffeine is processed. Regular consumption can lead to tolerance in some individuals, while others remain sensitive and experience stronger effects from the same dose.
Short-term physiologic effects can include temporary increases in blood pressure, heart rate and blood sugar, along with increased alertness. Some people report palpitations or sleep disruption after caffeine intake.
Study results vary. In people with optimal blood pressure, drinking 1–3 cups of caffeinated coffee per day was associated in some analyses with an increased risk of developing high blood pressure, whereas drinking more than 3 cups per day was associated with a lower risk in other analyses. High doses of caffeine—such as those delivered by energy drinks and energy shots—can substantially raise blood pressure, especially in people who already have elevated blood pressure.
Regular consumption of black caffeinated coffee (without additives) has been linked in observational studies to a lower risk of developing Type 2 diabetes. Experimental work suggests caffeine may reduce insulin sensitivity in the short term, but the prospective protective association seen with coffee could be driven by noncaffeine compounds in coffee. More research is needed to separate caffeine’s effects from those of other coffee constituents.
Randomized clinical trial data identify cafestol, a coffee compound present in unfiltered coffee forms (espresso, French press, Turkish or boiled coffee), as associated with increases in low-density lipoprotein (LDL) cholesterol. Cafestol is largely absent from paper-filtered or instant coffee. Additional study is required to determine which brewing methods and commercial products contain higher cafestol levels and how they influence lipid profiles.
Overall analyses that used self-reported intake found that drinking 1–3 cups of caffeinated coffee per day was not associated with a higher risk of atrial fibrillation or broad abnormal heart rhythm. However, that level of consumption may be associated with more premature ventricular contractions (PVCs), which are early beats from the heart’s lower chambers. Randomized trials have shown a lower risk of atrial fibrillation with caffeine in coffee but also a higher risk of PVCs.
Very high caffeine doses—such as those found in many caffeinated energy drinks or energy shots—have been linked to abnormal heart rhythms even in people usually considered low cardiovascular risk, including healthy younger adults.
Observational evidence has linked drinking 2–4 cups of caffeinated coffee per day to a lower risk of coronary heart disease, heart failure and stroke in some studies. Nonetheless, drinking more than 4 cups per day has been associated in some analyses with an increased risk of heart failure. These findings are not uniformly consistent and cannot establish cause and effect.
Not all sources of caffeine are equivalent. Coffee is the most common source studied, but tea, chocolate, soda, energy drinks and caffeine-containing medications also contribute to total intake. Tea has been associated with reduced risk of atrial fibrillation, heart failure and stroke in some research, though fewer studies focus on tea than coffee.
Energy drinks, bars, gels and concentrated caffeine supplements often deliver much higher caffeine concentrations per fluid ounce and may include other ingredients that increase caffeine absorption or potentiate cardiovascular effects. For example, energy drink shots may contain roughly three to four times the caffeine concentration of regular caffeinated coffee, and these products have been linked to increased blood pressure and arrhythmia risk.
The writing group highlighted several research gaps: more randomized controlled trials are needed to investigate caffeine’s cardiovascular effects across different products and populations; studies should better characterize caffeine content across beverages and foods; and research is required to clarify how caffeine’s effects vary by individual characteristics (age, genetics, comorbidities, medications and metabolism).
Because current data are insufficiently rigorous to produce prescriptive intake recommendations, the Association did not include caffeine guidance in its 2026 Dietary Guidance to Improve Cardiovascular Health. The statement calls for prioritized research on caffeinated energy drinks and other popular caffeine-containing products.
The scientific statement recommends that for most adults, consuming up to 400 mg of caffeine per day—equivalent to up to about five 8-ounce cups of regular, black caffeinated coffee without added sugars or fillers—is considered safe. Clinicians should be aware that individual responses vary: some patients may experience palpitations, anxiety or sleep disturbances at lower doses.
Patients should be counseled to consider total caffeine intake from all sources (coffee, tea, soda, energy products, chocolate and medications) and to avoid high-dose energy drinks or concentrated caffeine shots. Attention to brewing methods is relevant for cholesterol risk because unfiltered coffee contains cafestol. Clinicians and patients should discuss personal risk factors, symptoms after caffeine intake and how best to tailor consumption.
The statement clarifies that scientific statements summarize current evidence and identify research needs; they do not provide formal clinical practice recommendations. Health care teams should individualize advice based on patient history, comorbidities, medications and tolerance to caffeine.